Biotech

All Articles

Roche tosses out $120M tau possibility, giving back civil rights to UCB

.Roche has sent back the rights to UCB's anti-tau antibody bepranemab, leaving a $120 thousand bank ...

Editas boosts in vivo approach by means of $238M Genenvant deal

.Editas Medicines has actually signed a $238 million biobucks pact to mix Genevant Scientific resear...

Combo results, Vicodin miss and also outstanding protection

.Vertex has actually reported stage 3 data on its own near-approval discomfort medication candidate ...

Angelini pens $360M biobucks treaty for ph. 1 human brain disorder medication

.Italy's Angelini Pharma has actually authorized a $360 million biobucks pact centered on a stage 1-...

Sage lays off one-half of R&ampD crew and also agitates C-suite again

.Sage Therapies' newest try to reduce its own pipeline as well as labor force will definitely find a...

With stage 1 data, Mood has an eye on early-stage bladder cancer cells

.Along with its own lead prospect in a phase 3 test for a rare eye cancer, Feeling Biosciences is wa...

Less than a year in, BenevolentAI chief executive officer is out-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of significant management hirings, firings a...

Roche MAGE-A4 trial taken out after critical testimonial

.Roche has actually created one more MAGE-A4 course disappear, taking out a period 1 trial of a T-ce...

FDA puts partial hang on BioNTech-OncoC4 phase 3 trial

.The FDA has actually implemented a predisposed hold on a period 3 non-small cell bronchi cancer cel...

REGiMMUNE, Kiji merge to produce Treg 'super company,' program IPO

.Taiwan's REGiMMUNE and Europe-based Kiji Rehabs are actually merging to make a globally minded gove...